Treatment of Acanthamoeba keratitis with chlorhexidine

Ophthalmology

Volumn 106, Issue 4, 1999, Pages 798-802

  Kosrirukvongs, Panida ^a   Wanachiwanawin, Darawan ^a   Visvesvara, Govinda S ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CHLORHEXIDINE; CLOTRIMAZOLE; GENTAMICIN; NEOMYCIN; POLYMYXIN; TOBRAMYCIN;

ACANTHAMOEBA; ADULT; AGED; AMEBIASIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONVALESCENCE; DRUG EFFICACY; FEMALE; HEALING; HUMAN; KERATITIS; MALE; PRIORITY JOURNAL; SYMPTOMATOLOGY; VISUAL ACUITY;

EID: 0033511976     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)90169-0     Document Type: Article

References (49)

1. Jones DB. Acanthamoeba - the ultimate opportunist? Am J Ophthalmol 1986;102:527-30.
2. Bacon AS, Dart JKG, Ficker LA, et al. Acanthamoeba keratitis. The value of early diagnosis. Ophthalmology 1993;100: 1238-43.
3. Wright P, Warhurst D, Jones BR. Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol 1985;69: 778-82.
4. McClellan K, Coster DJ. Acanthamoebic keratitis diagnosed by paracentesis and biopsy and treated with propamidine. Br J Ophthalmol 1987;71:734-6.
5. John T, Lin J, Sahm DF. Acanthamoeba keratitis successfully treated with prolonged propamidine isethionate and neomycin-polymyxin-gramicidin. Ann Ophthalmol 1990;22:20-3.
6. Driebe W T Jr., Stern GA, Epstein RJ, et al. Acanthamoeba keratitis. Potential role for topical clotrimazole in combination chemotherapy. Arch Ophthalmol 1988;106:1196-201.
7. Ishibashi Y, Matsumoto Y, Kabata T, et al. Oral itraconazole and topical miconazole with debridement for Acanthamoeba keratitis. Am J Ophthalmol 1990;109:121-6.
8. Brasseur G, Favennec L, Perrine D, et al. Successful treatment of Acanthamoeba keratitis by hexamidine. Cornea 1994;13: 459-62.
9. Ficker L, Seal D, Warhurst D, Wright P. Acanthamoeba keratitis - resistance to medical therapy. Eye 1990;4:835-8.
10. Johns KJ, Head WS, O'Day DM. Corneal toxicity of propamidine. Arch Ophthalmol 1988;106:68-9.
11. Byers TJ, Kim BG, King LE, Hugo ER. Molecular aspects of the cell cycle and encystment of Acanthamoeba. Rev Infect Dis 1991;13(Suppl 5):S373-84.
12. Meisler DM, Ludwig IH, Rutherford I, et al. Susceptibility of Acanthamoeba to cryotherapeutic method. Arch Ophthalmol 1986;104:130-1.
13. Matoba AY, Pare PD, Le TD, Osato MS. The effects of freezing and antibiotics on the viability of Acanthamoeba cysts. Arch Ophthalmol 1989;107:439-40.
14. Brooks JG Jr., Coster DJ, Badenoch PR. Acanthamoeba keratitis. Resolution after epithelial debridement. Cornea 1994; 13:186-9.
15. Peterson RJ, Smith ME, Pepose JS. Recurrent Acanthamoeba keratitis following penetrating keratoplasty. Arch Ophthalmol 1990;108:1482-3.
16. Elder MJ, Kilvington S, Dart JKG. A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 1994;35:1059-64.
17. Larkin DF, Kilvington S, Dart JKG. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 1992;99:185-91.
18. Varga JH, Wolf TC, Jensen HG, et al. Combined treatment of Acanthamoeba keratitis with propamidine, neomycin, and polyhexamethylene biguanide. Am J Ophthalmol 1993;115: 466-70.
19. Duguid IGM, Dart JKG, Morlet N, et al. Outcome of Acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology 1997;104:1587-92.
20. Hay J, Kirkness C M, Seal D V, Wright P. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy. Eye 1994;8:555-63.
21. Booth A, Morrell AJ. Treatment of Acanthamoeba keratitis [letter]. Eye 1994;8:719-20.
22. McCulley JP, Alizadeh H, Niederkorn JY. Acanthamoeba keratitis. CLAO J 1995;21:73-6.
23. Bacon AS, Frazer DG, Dart JKG, et al. A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992. Eye 1993;7:719-25.
24. Moore MB, McCulley JP, Newton C, et al. Acanthamoeba keratitis. A growing problem in soft and hard contact lens wearers. Ophthalmology 1987;94:1654-61.
25. Koenig SB, Solomon JM, Hyndiuk RA, et al. Acanthamoeba keratitis associated with gas-permeable contact lens wear [letter]. Am J Ophthalmol 1987;103:832.
26. Ficker L, Hunter P, Seal D, Wright P. Acanthamoeba keratitis occurring with disposable contact lens wear [letter]. Am J Ophthalmol 1989;108:453.
27. Srinivasan M, Channa P, Raju CV, George C. Acanthamoeba keratitis in hard contact lens wearer. Indian J Ophthalmol 1993;41:187-8.
28. Moore MB, McCulley JP. Acanthamoeba keratitis associated with contact lenses: six consecutive cases of successful management. Br J Ophthalmol 1989;73:271-5.
29. Tachikawa T, Ishibashi Y, Fujisawa S, et al. A nation-wide survey on the occurrence of amoebic keratitis in Japan [in Japanese]. Nippon Ganka Gakkai Zasshi 1995;99:68-75.
30. Stehr-Green JK, Bailey TM, Visvesvara GS. The epidemiology of Acanthamoeba keratitis in the United States. Am J Ophthalmol 1989;107:331-6.
31. Asbell PA. Acanthamoeba keratitis: there and back again. Mt. Sinai J Med 1993;60:279-82.
32. Sharma S, Srinivasan M, George C. Acanthamoeba keratitis in non-contact lens wearers. Arch Ophthalmol 1990;108:676-8.
33. Chang PCT, Soong HK. Acanthamoeba keratitis in non-contact lens wearers [letter]. Arch Ophthalmol 1991;109:463-4.
34. Parrish CM, Head WS, O'Day DM, Rowlett W. Acanthamoeba keratitis following keratoplasty without other identifiable risk factors [letter]. Arch Ophthalmol 1991;109:471.
35. Chynn EW, Lopez MA, Pavan-Langston D, Talamo JH. Acanthamoeba keratitis. Contact lens and noncontact lens characteristics. Ophthalmology 1995;102:1369-73.
36. Cohen EJ, Buchanan HW, Laughrea PA, et al. Diagnosis and management of Acanthamoeba keratitis. Am J Ophthalmol 1985;100:389-95.
37. van Klink F, Alizadeh H, Stewart GL, et al. Characterization and pathogenic potential of a soil isolate and an ocular isolate of Acanthamoeba castellanii in relation to Acanthamoeba keratitis. Curr Eye Res 1992;11:1207-20.
38. Holland EJ, Alul IH, Meisler DM, et al. Subepithelial infiltrates in Acanthamoeba keratitis. Am J Ophthalmol 1991;112: 414-8.
39. Biavasco F, Manso E, Giovannini A, et al. Bilateral Acanthamoeba keratitis. Clin Infect Dis 1994;18:661-2.
40. Illingworth CD, Cook SD, Karabatsas CH, Easty DL. Acanthamoeba keratitis: risk factors and outcome. Br J Ophthalmol 1995;79:1078-82.
41. Tay-Kearney ML, McGhee CNJ, Crawford GJ, Trown K. Acanthamoeba keratitis. A masquerade of presentation in six cases. Aust N Z J Ophthalmol 1993;21:237-45.
42. D'Aversa G, Stern GA, Driebe WT Jr. Diagnosis and successful medical treatment of Acanthamoeba keratitis. Arch Ophthalmol 1995;113:1120-3.
43. Lindquist TD. Treatment of Acanthamoeba keratitis. Cornea 1998;17:11-6.
44. Gray TB, Gross KA, Cursons RTM, Shewan JF. Acanthamoeba keratitis: a sobering case and a promising new treatment. Aust N Z J Ophthalmol 1994;22:73-6.
45. Ishibashi Y. Acanthamoeba keratitis. Ophthalmologica 1997; 211(Suppl 1):39-44.
46. Green K, Livingston V, Bowman K, Hull DS. Chlorhexidine effects on corneal epithelium and endothelium. Arch Ophthalmol 1980;98:1273-8.
47. Hay J, Seal DV. Acanthamoeba keratitis: risk factors and outcome [letter]. Br J Ophthalmol 1996;80:773.
48. Mathers WD, Sutphin JE, Folberg R, et al. Outbreak of keratitis presumed to be caused by Acanthamoeba. Am J Ophthalmol 1996;121:129-42.
49. Cohen EJ, Parlato CJ, Arentsen JJ, et al. Medical and surgical treatment of Acanthamoeba keratitis. Am J Ophthalmol 1987; 103:615-25.